RA
Rise Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-60
| Closed | -$2.82K | – | 1139 |
|
|
2024
Q3 | $2.82K | Hold |
60
| – | – | ﹤0.01% | 1110 |
|
|
2024
Q2 | $3.24K | Hold |
60
| – | – | ﹤0.01% | 1096 |
|
|
2024
Q1 | $4.09K | Hold |
60
| – | – | ﹤0.01% | 1099 |
|
|
2023
Q4 | $3.76K | Hold |
60
| – | – | ﹤0.01% | 406 |
|
|
2023
Q3 | $2.72K | Hold |
60
| – | – | ﹤0.01% | 435 |
|
|
2023
Q2 | $3.37K | Hold |
60
| – | – | ﹤0.01% | 451 |
|
|
2023
Q1 | $2.71K | Hold |
60
| – | – | ﹤0.01% | 532 |
|
|
2022
Q4 | $2.43K | Hold |
60
| – | – | ﹤0.01% | 536 |
|
|
2022
Q3 | $4K | Hold |
60
| – | – | ﹤0.01% | 459 |
|
|
2022
Q2 | $4K | Hold |
60
| – | – | ﹤0.01% | 467 |
|
|
2022
Q1 | $4K | Hold |
60
| – | – | ﹤0.01% | 444 |
|
|
2021
Q4 | $4.55K | Buy |
+60
| New | +$4.55K | ﹤0.01% | 415 |
|